• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    South America Intravenous Solution Market

    ID: MRFR/HC/43039-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    South America Intravenous Solution Market Research Report By Nutrition Type (Total Parenteral Nutrition, Peripheral Parenteral Nutrition), By Bag Type (Large Volume Bags (>250 ml), Small Volume Bags (250 ml)), By Nutritional Content (Amino Acid Solution, Carbohydrates, Vitamins Minerals, Parenteral Lipid Emulsion) and By End User (Hospital Clinics, Ambulatory Surgical Centers, Home Care)-Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    South America Intravenous Solution Market Research Report-Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    South America Intravenous Solution Market Summary

    The South America Intravenous Solution market is projected to grow significantly from 1.5 USD Billion in 2024 to 3.32 USD Billion by 2035.

    Key Market Trends & Highlights

    South America Intravenous Solution Key Trends and Highlights

    • The South America Intravenous Solution market is valued at 1.5 USD Billion in 2024.
    • By 2035, the market is expected to reach 3.32 USD Billion, indicating robust growth.
    • The compound annual growth rate (CAGR) from 2025 to 2035 is estimated at 7.49%.
    • Growing adoption of intravenous therapies due to increasing healthcare needs is a major market driver.

    Market Size & Forecast

    2024 Market Size 1.5 (USD Billion)
    2035 Market Size 3.32 (USD Billion)
    CAGR (2025-2035) 7.49%

    Major Players

    Hikma Pharmaceuticals, Baxter International, Fresenius Kabi, Daiichi Sankyo, McGaw, Inc., Grifols, B. Braun Melsungen, Otsuka Pharmaceutical, Octapharma, Mediworx, Eisai Co., Hospira, AMGEN, Vifor Pharma, Terumo Corporation

    South America Intravenous Solution Market Trends

    The South American intravenous solution market is undergoing a number of noteworthy changes that are indicative of the region's changing healthcare environment. The rising prevalence of chronic conditions, including diabetes, heart disease, and kidney disease, is one major factor propelling the market. The need for necessary medical treatments, such as intravenous solutions, has increased as populations in South American nations age and become more urbanized. Additionally, as IV solutions are essential for patient hydration and medicine delivery, the increase in surgical operations and hospital admissions is driving up demand for them.

    The development and application of sophisticated intravenous solutions, such as parenteral nutrition and solutions especially suited to individual patient requirements, has significantly increased in recent years. This trend is mostly driven by South America's increasing focus on customized medicine, which directs medical professionals to give therapies that are more suited to the unique characteristics of each patient. Similar to this, there are chances to increase the market reach of intravenous solutions due to growing government investments in healthcare infrastructure, especially in Brazil and Argentina. Additionally, producers are looking for ways to improve and innovate intravenous solution quality.

    New packaging technologies and intelligent infusion devices that improve patient safety and user experience are developed as a result of the emphasis on sterility, safety, and usefulness.

    ,The ongoing collaboration among healthcare professionals, manufacturers, and regulatory bodies aims to ensure compliance and improve healthcare delivery. Overall, these trends not only reflect advancements in medical practice but also highlight the region's potential for growth and innovation in the intravenous solutions sector.

    South America Intravenous Solution Market Drivers

    Market Segment Insights

    Intravenous Solution Market Nutrition Type Insights

    The South America Intravenous Solution Market exhibits significant growth driven by the Nutrition Type segment, which plays a crucial role in supporting patients with specific nutritional needs. Within this segment, Total Parenteral Nutrition (TPN) and Peripheral Parenteral Nutrition (PPN) represent two essential categories. TPN is generally employed for patients who are unable to consume food orally or through enteral feeding, providing complete nutrition directly into the bloodstream. This method is particularly critical in hospitals where patients experience severe gastrointestinal disorders, surgical recovery, or malnourishment.

    The increasing prevalence of chronic diseases and the rising geriatric population in South America act as significant growth drivers, necessitating the adoption of TPN solutions.Conversely, PPN is predominantly utilized for patients with less severe nutritional deficits who can tolerate some oral intake. It allows for the administration of a limited amount of nutrients through peripheral veins and is ideal for short-term nutritional therapy.

    The demand for PPN is increasing, as it offers healthcare providers flexible options to meet patients' needs without requiring central venous access.In South America, trends in the intravenous solution market indicate a notable shift towards more advanced formulations and the incorporation of additional electrolytes and vitamins, reflecting a growing awareness of personalized nutrition in patient care. This adaptation responds to the rise in lifestyle-related diseases, which has necessitated a more tailored approach to intravenous nutrition therapy.

    While TPN continues to dominate due to its comprehensive approach to nutrition, PPN is gaining traction as a viable alternative, offering a strategic option to healthcare providers. Challenges in the Nutrition Type segment include stringent regulations regarding intravenous solutions, along with the need for healthcare facilities to maintain the quality and stability of products. However, opportunities exist for innovation in product formulations and the development of novel delivery systems. This trend suggests a favorable outlook for the South America Intravenous Solution Market, where tailored nutritional solutions are increasingly recognized as an integral component of comprehensive healthcare.

    Overall, the Nutrition Type segment stands out as a vital part of the South America Intravenous Solution Market, underscoring the importance of meeting the diverse nutritional requirements of patients across the region.

    Intravenous Solution Market Bag Type Insights

    The South America Intravenous Solution Market has shown significant interest in Bag Type products, particularly focusing on Large Volume Bags and Small Volume Bags. Large Volume Bags are often utilized for sustained and continuous administration of fluids, making them vital in medical settings, especially in hospitals where patients require intensive care. Their ability to accommodate higher volumes ensures fewer interruptions during treatment, thus enhancing patient comfort and compliance. On the other hand, Small Volume Bags are critical for delivering concentrated medications or electrolytes, allowing for precise dosage and quick response to patient needs.

    Both categories are pivotal in addressing the diverse medical requirements seen across South America, where healthcare systems are adapting to growing patient populations and increasing demand for intravenous therapies. The emphasis on quality and safety associated with Bag Type products has contributed to their prominence in the broader South America Intravenous Solution Market, as healthcare providers strive to improve patient outcomes while navigating the challenges posed by varying regional healthcare standards and regulations.

    Intravenous Solution Market Nutritional Content Insights

    The South America Intravenous Solution Market within the Nutritional Content segment encompasses a variety of vital components, including amino acids, carbohydrates, vitamins, minerals, and parenteral lipid emulsions, each playing a critical role in patient care. Amino acid solutions are essential for individuals who cannot obtain adequate nutrition through oral intake, significantly benefiting those undergoing surgery or critical illnesses. Carbohydrate solutions provide essential energy sources for patients, addressing metabolic needs and enhancing recovery processes.Vitamins and minerals are indispensable for overall health and maintaining various body functions, making them crucial during intravenous therapy.

    Moreover, parenteral lipid emulsions offer necessary fatty acids, contributing to energy delivery and supporting tissue function. The region's increasing healthcare spending and a growing geriatric population are driving the demand for these nutritional components in intravenous solutions, reflecting an upward trend in both market growth and diversification of product offerings within the South America Intravenous Solution Market.Overall, the emphasis on improved patient outcomes and nutritional support highlights the significance of this segment in meeting the healthcare needs of the population in South America.

    Intravenous Solution Market End User Insights

    The South America Intravenous Solution Market, particularly in the End User category, showcases a diverse landscape encompassing Hospitals, Clinics, Ambulatory Surgical Centers, and Home Care settings. Hospitals Clinics are pivotal as they often represent the primary point of care for patients requiring intravenous therapies, where the demand continues to surge due to rising hospitalization rates and chronic illness prevalence in the region.

    Ambulatory Surgical Centers are increasingly significant as they expand access to day procedures, enhancing patient convenience and potentially reducing overall healthcare costs.The Home Care sector is also gaining traction, driven by the ongoing shift towards patient-centric care, allowing individuals to receive treatment in a comfortable environment while alleviating some of the burdens on healthcare facilities. Factors contributing to market growth in these areas include technological advancements in intravenous therapies and an increasing focus on improving patient outcomes. However, challenges such as regulatory hurdles and the need for trained healthcare professionals persist.

    Overall, the segmentation within the South America Intravenous Solution Market reveals critical insights into the evolving healthcare needs and treatment preferences specific to the region.

    Get more detailed insights about South America Intravenous Solution Market Research Report-Forecast to 2035

    Regional Insights

    Key Players and Competitive Insights

    The South America Intravenous Solution Market is evolving amid a landscape marked by increasing healthcare needs and a growing focus on patient-centric solutions. This market features a variety of players, each competing for market share by leveraging innovations in production, distribution, and specialized offerings. Strong regulatory frameworks and varying healthcare policies across South American nations add layers of complexity to this competitive environment. The market is characterized by the introduction of advanced IV solutions catering to diverse medical treatment protocols and the rise in chronic conditions requiring long-term management.

    Companies in this sector strive to enhance their operational efficiencies and quality control to meet the stipulations laid out by health authorities, ensuring that they stay relevant and competitive in an ever-evolving marketplace.Hikma Pharmaceuticals has established a significant foothold within the South America Intravenous Solution Market by emphasizing quality and accessibility in its product offerings. The company benefits from a well-diversified portfolio that includes a range of intravenous solutions aimed at treating multiple medical conditions. Hikma Pharmaceuticals is recognized for its commitment to innovation and continually improving its manufacturing capabilities to ensure the delivery of premium products.

    This commitment has helped the company build strong relationships with healthcare providers and patients alike, positioning it favorably in key territories of South America. Furthermore, Hikma's strategic focus on aligning with local needs demonstrates its agility in responding to the specific healthcare requirements of South American markets.Baxter International is a notable player in the South America Intravenous Solution Market, providing an array of products, including intravenous fluids and nutritional solutions that are integral to patient care. The company's strong presence in this region is underscored by its commitment to improving health outcomes through innovative therapeutic options.

    Key strengths of Baxter International include its extensive experience in the industry, widespread distribution networks, and a reputation for high-quality standards. The company's strategic initiatives, including mergers and acquisitions, have further enhanced its market position and broadened its product portfolio. Baxter’s focus on research and development allows it to introduce new technologies aimed at increasing efficiency in IV therapy, catering specifically to the evolving healthcare needs of South American patients. This ongoing dedication to enhancing its services and product range solidifies Baxter's role as a leader in the region, making significant contributions to critical healthcare solutions across diverse patient demographics.

    Key Companies in the South America Intravenous Solution Market market include

    Industry Developments

    Recent developments in the South America Intravenous Solution Market reflect a growing demand driven by increasing hospitalization rates and the rise of chronic diseases. Companies such as Hikma Pharmaceuticals and Baxter International are expanding their product portfolios to enhance patient care and respond to healthcare challenges across the region. In September 2023, Fresenius Kabi announced plans to expedite the production of intravenous solutions to meet rising orders amidst a global supply chain crisis, indicating a pivotal shift in operational strategies.

    Meanwhile, Grifols launched a new line of specialized intravenous solutions aimed at addressing the specific health needs in Brazil, showcasing innovation in this sector. Merger and acquisition activities in the region remain notable; in July 2023, B. Braun Melsungen acquired a local competitor, further consolidating its presence in South America. Market valuations for Terumo Corporation have shown steady growth, fueled by increasing investments in healthcare infrastructure. Additionally, the South American market is witnessing significant changes as governments focus on improving healthcare accessibility, which directly influences the demand dynamics for intravenous solutions across countries like Argentina and Brazil.

    This sector is poised for continuous growth as suppliers adapt to evolving healthcare needs and regulatory landscapes.

    Market Segmentation

    Outlook

    • Hospital Clinics
    • Ambulatory Surgical Centers
    • Home Care

    Intravenous Solution MarketEnd UserOutlook

    • Hospital Clinics
    • Ambulatory Surgical Centers
    • Home Care

    Intravenous Solution MarketNutrition TypeOutlook

    • Total Parenteral Nutrition
    • Peripheral Parenteral Nutrition
    • Large Volume Bags (>250 ml)
    • Small Volume Bags (250 ml)
    • Intravenous Solution MarketNutritional ContentOutlook

    Intravenous Solution MarketNutritional ContentOutlook

    • Amino Acid Solution
    • Carbohydrates
    • Vitamins Minerals
    • Parenteral Lipid Emulsion
    • Intravenous Solution MarketEnd UserOutlook

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 1.39(USD Billion)
    MARKET SIZE 2024 1.5(USD Billion)
    MARKET SIZE 2035 3.32(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 7.499% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED Hikma Pharmaceuticals, Baxter International, Fresenius Kabi, Daiichi Sankyo, McGaw, Inc., Grifols, B. Braun Melsungen, Otsuka Pharmaceutical, Octapharma, Mediworx, Eisai Co., Hospira, AMGEN, Vifor Pharma, Terumo Corporation
    SEGMENTS COVERED Nutrition Type, Bag Type, Nutritional Content, End User
    KEY MARKET OPPORTUNITIES Growing aging population, Increasing chronic diseases prevalence, Expanding healthcare infrastructure, Rising demand for outpatient services, Advancements in IV technology
    KEY MARKET DYNAMICS rising chronic diseases, growing geriatric population, increased healthcare expenditure, technological advancements, regulatory compliance challenges
    COUNTRIES COVERED Brazil, Mexico, Argentina, Rest of South America

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the projected market size of the South America Intravenous Solution Market in 2024?

    The South America Intravenous Solution Market is projected to be valued at 1.5 billion USD in 2024.

    What will be the market value of the South America Intravenous Solution Market by 2035?

    By 2035, the market is expected to reach a valuation of 3.32 billion USD.

    What is the expected CAGR for the South America Intravenous Solution Market from 2025 to 2035?

    The market is anticipated to experience a compound annual growth rate of 7.499 percent from 2025 to 2035.

    Which nutrition type segment is expected to dominate the South America Intravenous Solution Market in 2024?

    In 2024, the Total Parenteral Nutrition segment is valued at 0.85 billion USD, making it a significant portion of the market.

    How is the Peripheral Parenteral Nutrition segment expected to grow by 2035?

    The Peripheral Parenteral Nutrition segment is projected to increase to 1.47 billion USD by 2035.

    Who are the key players in the South America Intravenous Solution Market?

    Major players include Hikma Pharmaceuticals, Baxter International, and Fresenius Kabi among others.

    What market opportunities and trends are emerging in the South America Intravenous Solution Market?

    Growing healthcare needs and advancements in nutritional therapies present significant opportunities for market growth.

    What are the expected challenges in the South America Intravenous Solution Market?

    Challenges may include regulatory hurdles and the need for technological advancements in manufacturing.

    How will the competitive landscape impact the market in the coming years?

    Increased competition from established players and new entrants is likely to drive innovation and pricing strategies.

    What is the expected growth rate for the Total Parenteral Nutrition segment by 2035?

    The Total Parenteral Nutrition segment is expected to grow to 1.85 billion USD by 2035.

    1. EXECUTIVE SUMMARY
    2. Market Overview
    3. Key Findings
    4. Market Segmentation
    5. Competitive Landscape
    6. Challenges and Opportunities
    7. Future Outlook
    8. MARKET INTRODUCTION
    9. Definition
    10. Scope of the study
    11. Research Objective
    12. Assumption
    13. Limitations
    14. RESEARCH METHODOLOGY
    15. Overview
    16. Data Mining
    17. Secondary Research
    18. Primary Research
    19. Primary Interviews and Information Gathering Process
    20. Breakdown of Primary Respondents
    21. Forecasting Model
    22. Market Size Estimation
    23. Bottom-Up Approach
    24. Top-Down Approach
    25. Data Triangulation
    26. Validation
    27. MARKET DYNAMICS
    28. Overview
    29. Drivers
    30. Restraints
    31. Opportunities
    32. MARKET FACTOR ANALYSIS
    33. Value chain Analysis
    34. Porter's Five Forces Analysis
    35. Bargaining Power of Suppliers
    36. Bargaining Power of Buyers
    37. Threat of New Entrants
    38. Threat of Substitutes
    39. Intensity of Rivalry
    40. COVID-19 Impact Analysis
    41. Market Impact Analysis
    42. Regional Impact
    43. Opportunity and Threat Analysis
    44. South America Intravenous Solution Market, BY Nutrition Type (USD Billion)
    45. Total Parenteral Nutrition
    46. Peripheral Parenteral Nutrition
    47. South America Intravenous Solution Market, BY Bag Type (USD Billion)
    48. Large Volume Bags (>250 ml)
    49. Small Volume Bags (250 ml)
    50. South America Intravenous Solution Market, BY Nutritional Content (USD Billion)
    51. Amino Acid Solution
    52. Carbohydrates
    53. Vitamins Minerals
    54. Parenteral Lipid Emulsion
    55. South America Intravenous Solution Market, BY End User (USD Billion)
    56. Hospital Clinics
    57. Ambulatory Surgical Centers
    58. Home Care
    59. Competitive Landscape
    60. Overview
    61. Competitive Analysis
    62. Market share Analysis
    63. Major Growth Strategy in the Intravenous Solution Market
    64. Competitive Benchmarking
    65. Leading Players in Terms of Number of Developments in the Intravenous Solution Market
    66. Key developments and growth strategies
    67. New Product Launch/Service Deployment
    68. Merger Acquisitions
    69. Joint Ventures
    70. Major Players Financial Matrix
    71. Sales and Operating Income
    72. Major Players RD Expenditure. 2023
    73. Company Profiles
    74. Hikma Pharmaceuticals
    75. Financial Overview
    76. Products Offered
    77. Key Developments
    78. SWOT Analysis
    79. Key Strategies
    80. Baxter International
    81. Financial Overview
    82. Products Offered
    83. Key Developments
    84. SWOT Analysis
    85. Key Strategies
    86. Fresenius Kabi
    87. Financial Overview
    88. Products Offered
    89. Key Developments
    90. SWOT Analysis
    91. Key Strategies
    92. Daiichi Sankyo
    93. Financial Overview
    94. Products Offered
    95. Key Developments
    96. SWOT Analysis
    97. Key Strategies
    98. McGaw, Inc.
    99. Financial Overview
    100. Products Offered
    101. Key Developments
    102. SWOT Analysis
    103. Key Strategies
    104. Grifols
    105. Financial Overview
    106. Products Offered
    107. Key Developments
    108. SWOT Analysis
    109. Key Strategies
    110. B. Braun Melsungen
    111. Financial Overview
    112. Products Offered
    113. Key Developments
    114. SWOT Analysis
    115. Key Strategies
    116. Otsuka Pharmaceutical
    117. Financial Overview
    118. Products Offered
    119. Key Developments
    120. SWOT Analysis
    121. Key Strategies
    122. Octapharma
    123. Financial Overview
    124. Products Offered
    125. Key Developments
    126. SWOT Analysis
    127. Key Strategies
    128. Mediworx
    129. Financial Overview
    130. Products Offered
    131. Key Developments
    132. SWOT Analysis
    133. Key Strategies
    134. Eisai Co.
    135. Financial Overview
    136. Products Offered
    137. Key Developments
    138. SWOT Analysis
    139. Key Strategies
    140. Hospira
    141. Financial Overview
    142. Products Offered
    143. Key Developments
    144. SWOT Analysis
    145. Key Strategies
    146. AMGEN
    147. Financial Overview
    148. Products Offered
    149. Key Developments
    150. SWOT Analysis
    151. Key Strategies
    152. Vifor Pharma
    153. Financial Overview
    154. Products Offered
    155. Key Developments
    156. SWOT Analysis
    157. Key Strategies
    158. Terumo Corporation
    159. Financial Overview
    160. Products Offered
    161. Key Developments
    162. SWOT Analysis
    163. Key Strategies
    164. References
    165. Related Reports
    166. South America Intravenous Solution Market SIZE ESTIMATES & FORECAST, BY NUTRITION TYPE, 2019-2035 (USD Billions)
    167. South America Intravenous Solution Market SIZE ESTIMATES & FORECAST, BY BAG TYPE, 2019-2035 (USD Billions)
    168. South America Intravenous Solution Market SIZE ESTIMATES & FORECAST, BY NUTRITIONAL CONTENT, 2019-2035 (USD Billions)
    169. South America Intravenous Solution Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)
    170. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    171. ACQUISITION/PARTNERSHIP
    172. MARKET SYNOPSIS
    173. SOUTH AMERICA INTRAVENOUS SOLUTION MARKET ANALYSIS BY NUTRITION TYPE
    174. SOUTH AMERICA INTRAVENOUS SOLUTION MARKET ANALYSIS BY BAG TYPE
    175. SOUTH AMERICA INTRAVENOUS SOLUTION MARKET ANALYSIS BY NUTRITIONAL CONTENT
    176. SOUTH AMERICA INTRAVENOUS SOLUTION MARKET ANALYSIS BY END USER
    177. KEY BUYING CRITERIA OF INTRAVENOUS SOLUTION MARKET
    178. RESEARCH PROCESS OF MRFR
    179. DRO ANALYSIS OF INTRAVENOUS SOLUTION MARKET
    180. DRIVERS IMPACT ANALYSIS: INTRAVENOUS SOLUTION MARKET
    181. RESTRAINTS IMPACT ANALYSIS: INTRAVENOUS SOLUTION MARKET
    182. SUPPLY / VALUE CHAIN: INTRAVENOUS SOLUTION MARKET
    183. INTRAVENOUS SOLUTION MARKET, BY NUTRITION TYPE, 2024 (% SHARE)
    184. INTRAVENOUS SOLUTION MARKET, BY NUTRITION TYPE, 2019 TO 2035 (USD Billions)
    185. INTRAVENOUS SOLUTION MARKET, BY BAG TYPE, 2024 (% SHARE)
    186. INTRAVENOUS SOLUTION MARKET, BY BAG TYPE, 2019 TO 2035 (USD Billions)
    187. INTRAVENOUS SOLUTION MARKET, BY NUTRITIONAL CONTENT, 2024 (% SHARE)
    188. INTRAVENOUS SOLUTION MARKET, BY NUTRITIONAL CONTENT, 2019 TO 2035 (USD Billions)
    189. INTRAVENOUS SOLUTION MARKET, BY END USER, 2024 (% SHARE)
    190. INTRAVENOUS SOLUTION MARKET, BY END USER, 2019 TO 2035 (USD Billions)
    191. BENCHMARKING OF MAJOR COMPETITORS

    South America Intravenous Solution Market Segmentation

    • Intravenous Solution Market By Nutrition Type (USD Billion, 2019-2035)

      • Total Parenteral Nutrition
      • Peripheral Parenteral Nutrition
    • Intravenous Solution Market By Bag Type (USD Billion, 2019-2035)

      • Large Volume Bags (>250 ml)
      • Small Volume Bags (250 ml)
    • Intravenous Solution Market By Nutritional Content (USD Billion, 2019-2035)

      • Amino Acid Solution
      • Carbohydrates
      • Vitamins Minerals
      • Parenteral Lipid Emulsion
    • Intravenous Solution Market By End User (USD Billion, 2019-2035)

      • Hospital Clinics
      • Ambulatory Surgical Centers
      • Home Care

    Intravenous Solution Market Regional Outlook (USD Billion, 2019-2035)

    • South America Outlook (USD Billion, 2019-2035)

      • South America Intravenous Solution Market by Nutrition Type

        • Total Parenteral Nutrition
        • Peripheral Parenteral Nutrition
      • South America Intravenous Solution Market by Bag Type

        • Large Volume Bags (>250 ml)
        • Small Volume Bags (250 ml)
      • South America Intravenous Solution Market by Nutritional Content Type

        • Amino Acid Solution
        • Carbohydrates
        • Vitamins Minerals
        • Parenteral Lipid Emulsion
      • South America Intravenous Solution Market by End User Type

        • Hospital Clinics
        • Ambulatory Surgical Centers
        • Home Care
      • BRAZIL Outlook (USD Billion, 2019-2035)
      • BRAZIL Intravenous Solution Market by Nutrition Type

        • Total Parenteral Nutrition
        • Peripheral Parenteral Nutrition
      • BRAZIL Intravenous Solution Market by Bag Type

        • Large Volume Bags (>250 ml)
        • Small Volume Bags (250 ml)
      • BRAZIL Intravenous Solution Market by Nutritional Content Type

        • Amino Acid Solution
        • Carbohydrates
        • Vitamins Minerals
        • Parenteral Lipid Emulsion
      • BRAZIL Intravenous Solution Market by End User Type

        • Hospital Clinics
        • Ambulatory Surgical Centers
        • Home Care
      • MEXICO Outlook (USD Billion, 2019-2035)
      • MEXICO Intravenous Solution Market by Nutrition Type

        • Total Parenteral Nutrition
        • Peripheral Parenteral Nutrition
      • MEXICO Intravenous Solution Market by Bag Type

        • Large Volume Bags (>250 ml)
        • Small Volume Bags (250 ml)
      • MEXICO Intravenous Solution Market by Nutritional Content Type

        • Amino Acid Solution
        • Carbohydrates
        • Vitamins Minerals
        • Parenteral Lipid Emulsion
      • MEXICO Intravenous Solution Market by End User Type

        • Hospital Clinics
        • Ambulatory Surgical Centers
        • Home Care
      • ARGENTINA Outlook (USD Billion, 2019-2035)
      • ARGENTINA Intravenous Solution Market by Nutrition Type

        • Total Parenteral Nutrition
        • Peripheral Parenteral Nutrition
      • ARGENTINA Intravenous Solution Market by Bag Type

        • Large Volume Bags (>250 ml)
        • Small Volume Bags (250 ml)
      • ARGENTINA Intravenous Solution Market by Nutritional Content Type

        • Amino Acid Solution
        • Carbohydrates
        • Vitamins Minerals
        • Parenteral Lipid Emulsion
      • ARGENTINA Intravenous Solution Market by End User Type

        • Hospital Clinics
        • Ambulatory Surgical Centers
        • Home Care
      • REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)
      • REST OF SOUTH AMERICA Intravenous Solution Market by Nutrition Type

        • Total Parenteral Nutrition
        • Peripheral Parenteral Nutrition
      • REST OF SOUTH AMERICA Intravenous Solution Market by Bag Type

        • Large Volume Bags (>250 ml)
        • Small Volume Bags (250 ml)
      • REST OF SOUTH AMERICA Intravenous Solution Market by Nutritional Content Type

        • Amino Acid Solution
        • Carbohydrates
        • Vitamins Minerals
        • Parenteral Lipid Emulsion
      • REST OF SOUTH AMERICA Intravenous Solution Market by End User Type

        • Hospital Clinics
        • Ambulatory Surgical Centers
        • Home Care
    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials